Sector pending / Medical, Dental, and Hospital Equipment and SuppliesUpdated 2026-05-10 22:07 UTC

KLSE/LACMED stock hub

KLSE/LACMED has a live ticker hub with the latest available market, valuation, profitability, growth, ownership, and risk indicators.

Browse stocks

KLSE/LACMEDis not in this month’s coverageGet our monthly research letter — no spam

Fair value midpoint

n/a

Fair value pending

Upside to midpoint

n/a

Based on latest report

Confidence

n/a

Data quality and model convergence

Market cap

322M

Bursa Malaysia

Market data

Live price

Current market quote for this ticker.

Current price

KLSE/LACMED

In the news

Latest news · KLSE/LACMED

Recent company headlines from major financial publishers.

—

Fetching the latest headlines.

—

Fetching the latest headlines.

—

Fetching the latest headlines.

Calendar

Next earnings

Upcoming earnings date and setup when available.

Upcoming

DateLoading

Window—

EPS estimate—

Revenue estimate—

Sector context

Where the current metrics sit

Percentiles come from the backend screener cohort cache for the ticker's country and sector.

Forward P/En/a

P25 n/aP50 n/aP75 n/a

Trailing P/E4.3

P25 n/aP50 n/aP75 n/a

ROE26.3

P25 n/aP50 n/aP75 n/a

ROIC44.3

P25 n/aP50 n/aP75 n/a

Benchmarks - 1M

S&P 500n/a

Nasdaq Compositen/a

Dow Jones Industrial Averagen/a

Russell 2000n/a

Indicator catalog

All KLSE/LACMED market and fundamental indicators

A searchable catalog of the available market, valuation, profitability, growth, balance-sheet, ownership, and analyst metrics for this ticker.

Available fields

167

Groups with data

Currency

MYR

Showing 167 of 167 available metrics for this ticker.

Profile and market data

Ticker identity, listing, currency, market cap, and source dates.

Metric	Value
Country	Malaysia
Country code	MY
Employees	100
Employees Change	16%
Employees Change Percent	19.05
Enterprise value	MYR 261.5M
Exchange	Bursa Malaysia
Financial currency	MYR
First seen	2026-05-10
Industry	Medical, Dental, and Hospital Equipment and Supplies
Last refreshed	2026-05-10
Market cap	MYR 322M
Price	MYR 0.81
Price currency	MYR
Rev Per Employee	2,016,550.82x
Sic	5047
Symbol	klse/LACMED
Website	https://www.lacmed.com

Valuation

Multiples, yields, enterprise-value ratios, and valuation checks.

Metric	Value
Earnings Yield	6.83%
EV Earnings	11.89x
EV/EBIT	8.57x
EV/EBITDA	8.22x
EV/FCF	-28.78x
EV/Sales	1.3x
FCF yield	-2.82%
P/B ratio	2.71x
P/E ratio	4.27x
P/S ratio	1.6x

Profitability

Margins, returns on capital, cash conversion, and quality metrics.

Metric	Value
EBIT Margin	15.13%
EBITDA Margin	15.7%
Gross margin	29.05%
Gross Profit	MYR 58.6M
Gross Profit Growth	22.98%
Gross Profit Growth Q	40.2%
Net Income	MYR 22M
Net Income Growth	5.99%
Net Income Growth Q	31.5%
Pretax Margin	15.37%
Profit Margin	10.9%
Profit Per Employee	MYR 219,861
ROA	11.11
ROCE	25.41
ROE	26.29
ROIC	44.26

Growth

Revenue, earnings, cash-flow, and forward growth indicators.

Metric	Value
EPS Growth	-98.18
EPS Growth Q	-98.86
OCF Growth	-98.34%
Revenue Growth	34.13x
Revenue Growth Q	12.98x

Financial strength

Debt, cash, solvency, accounting-quality, and balance-sheet signals.

Metric	Value
Asset Turnover	MYR 1.17
Assets	MYR 215.2M
Cash	MYR 83M
Current Assets	MYR 200.5M
Current Liabilities	MYR 95.1M
Debt	MYR 22.5M
Debt EBITDA	MYR 0.71
Debt Equity	MYR 0.19
Debt FCF	MYR -2.47
Equity	MYR 118.9M
Interest Coverage	39.87
Liabilities	MYR 96.3M
Long Term Assets	MYR 14.7M
Long Term Liabilities	MYR 1.2M
Net Cash	MYR 60.6M
Net Cash By Market Cap	MYR 18.81
Net Cash Growth	161.57%
Net Debt EBITDA	MYR -1.91
Net Debt Equity	MYR -0.51
Tangible Book Value	MYR 116M
Tangible Book Value Per Share	MYR 0.29

Liquidity

Current-asset coverage and working-capital efficiency metrics.

Metric	Value
Current ratio	2.11
Inventory Turnover	5.89
Net Working Capital	MYR 43.6M
Quick ratio	1.73
Working Capital	MYR 105.4M
Working Capital Turnover	MYR 2.68

Dividends and buybacks

Dividend yield, payout, buybacks, and shareholder-yield indicators.

Metric	Value
Buyback Yield	-5,726.58%
Dividend per share	MYR 0.01
Dividend Yield	0.81%
Payout Ratio	22.74%

Performance and technicals

Returns, volatility, beta, momentum, RSI, and moving-average context.

Metric	Value
50-day SMA	0.87
All Time High	1.34
All Time High Change	-39.55%
All Time High Date	2026-01-12
All Time Low	0.75
All Time Low Change	8%
All Time Low Date	2025-12-10
ATR	0.03
Beta1y	0.32
Ch YTD	-8.99
High	0.81
High52	1.34
High52 Date	2026-01-12
High52ch	-39.93%
Low	0.81
Low52	0.75
Low52 Date	2025-12-10
Low52ch	7.33%
Ma50ch	-6.39%
RSI	36.66
RSI Monthly	0
RSI Weekly	52.27
Sharpe ratio	0.46x
Sortino ratio	0.84
Total Return	-5,725.77%
Tr YTD	-8.99
Tr1m	-8.47%
Tr1w	-1.82%
Tr3m	-17.35%

Analyst estimates

Ratings, targets, revisions, and forward estimate fields.

Metric	Value
Operating Income	MYR 30.5M
Operating Income Growth	16.59
Operating Income Growth Q	43.48
Operating margin	15.13

Ownership and float

Institutional, insider, float, short-interest, and share-count fields.

Metric	Value
Float	74,910,300%
Net Borrowing	6,799,122
Shares Insiders	81.27%
Shares Institutions	2.17%
Shares Out	400,000,000
Shares Qo Q	11,395.07%
Shares Yo Y	5,726.58%

Other indicators

Additional ticker metrics that do not fit the primary research groupings yet.

Metric	Value
Adjusted FCF	MYR -9.1M
Average Volume	1,102,980x
Bv Per Share	0.3
CAPEX	MYR -9.5M
Ch1m	-8.47
Ch1w	-1.82
Ch3m	-17.35
Change	-0.62%
Change From Open	-0.62
Close	0.81
Days Gap	0
Depreciation Amortization	1,140,788
Dollar Volume	236,992
Earnings Date	2026-06-05
EBIT	MYR 30.5M
EBITDA	MYR 31.7M
EPS	MYR 0.19
F Score	6
FCF	MYR -9.1M
FCF EV Yield	-3.47x
FCF Per Share	MYR -0.02
Financing CF	52,084,493
Fiscal Year End	December
Founded	2,003
Graham Number	1.12306
Graham Upside	38.65
Income Tax	MYR 9.1M
Investing CF	-1,367,613
Is Primary Listing	1
Last Report Date	2025-12-31
Ma20	0.86
Ma20ch	-5.74%
Net CF	50,812,974
Next Earnings Date	2026-06-05
Open	0.81
P OCF Ratio	855.6
Position In Range	0
Ppne	9,813,986
Price Date	2026-05-08
Price EBITDA	MYR 10.17
Ptbv Ratio	2.78
Relative Volume	0.27x
Revenue	201,655,082x
Tax By Revenue	4.5x
Tax Rate	29.27%
Volume	294,400
Z Score	4.61

Fast facts

Decision checkpoints

A compact product layer over the same report payload.

Risk gate

n/a

Named kill scenarios are reviewed before any bullish rating can stand.

Moat score

n/a

Business quality stays separate from stock attractiveness.

Forward P/E

n/a

Valuation uses the full report model stack, not a single multiple.

Next action

Research pending

Final action steps are kept in the recommendation tab.

Income

KLSE/LACMED dividend yield, growth & safety

Yield, payout sustainability, and the multi-year growth streak.

Dividend yield

+0.8%

$0.01 annual per share

Payout ratio

+22.7%

Share of earnings returned as dividends. Below 60% is generally sustainable.

5Y dividend CAGR

n/a

Annualized growth of the per-share dividend

Total shareholder yield

-5725.8%

Dividend yield + buyback yield combined

Ownership

Who owns KLSE/LACMED?

Insider, institutional, and short-interest positioning.

Institutional ownership

+2.2%

Share of float held by funds and institutions

Insider ownership

+81.3%

Stake held by company insiders. Higher generally signals alignment.

Short interest

n/a

Float sold short by bearish positioning

Y/Y dilution

+5726.6%

Negative means the company is buying back shares.

Technical

KLSE/LACMED momentum and risk profile

RSI, moving-average stack, beta, and risk-adjusted return.

RSI (14)

36.7

Neutral momentum band

Price vs 200-day MA

n/a

50/200-day relationship not available

Beta (5Y)

n/a

Sensitivity to the broader market

Sharpe ratio

0.46

Risk-adjusted return — higher is better; >1.0 is solid.

Questions

About KLSE/LACMED

Hub-level FAQ points readers to the deeper analysis pages.

What is the current klse/LACMED stock rating?

klse/LACMED is currently shown with the latest rating in the latest report. The hub links directly to the full analysis surface where the rating, fair-value bridge, risks, and scorecard are documented together.

Where can I read the full klse/LACMED analysis?

The full report lives at /stocks/klse/LACMED/analysis. The bare ticker page is a product hub that summarizes the latest read and sends readers into the relocated analysis tabs without making the analysis surface depend on the hub.

What fair-value range is used for klse/LACMED?

The latest report frames klse/LACMED around the latest fair-value range. Treat that range as the entry point, then check the valuation, sensitivity, and bear-case tabs before making an investment decision.

How often is the klse/LACMED page updated?

The hub updates with the latest published stock report and live backend market data. The analysis pages remain reachable under /analysis, so a hub rollback does not remove the report reader.